Dr. Christopher Ryan Antolini, MD

Dr. Antolini practices at Denver Arthritis Clinic in Denver, Colorado.

Dr. Antolini's NPI, 1750302592, was assigned on July 21, 2006. Dr. Antolini graduated from West Virginia University School of Medicine in 2002. Dr. Antolini holds Colorado license 0046724.

Dr. Antolini's primary practice is Denver Arthritis Clinic, at 7111 E Lowry Blvd, Denver, CO 80230 in Denver County. The practice phone is (303) 394-2828.

Dr. Antolini's primary practice is Denver Arthritis Clinic in Denver, Colorado. Dr. Antolini is also affiliated with HCA HealthONE Rose. The medical group on file is Denver Arthritis Clinic. Dmand AI also links Dr. Antolini to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Antolini practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Antolini's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Antolini is licensed in Colorado.

CMS data shows 20,147 Medicare services from Dr. Antolini across 20 procedure codes in 2024, for 296 Medicare patients. Medicare paid $535,198 for them. Every service was in an office.

CMS counts 296 Medicare patients who saw Dr. Antolini in 2024. The largest group is 65 to 74, with 145 patients. 75% of them have arthritis, and 64% have high cholesterol. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Antolini's median patient age at 64, with 66% women.

In 2024, Dr. Antolini wrote 2,038 Medicare Part D claims for 322 patients. 88% of them were for generic drugs. CMS names the drug for 1,837 of them, across 41 drugs with 11 or more claims each, at $920,020 in total drug cost. In 2023, CMS named 1,646 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Antolini for performance year 2024, reported individually. Dr. Antolini accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Antolini as offering telehealth.

Dmand AI links Dr. Antolini to 11 clinical trials, 6 of them phase 3 studies. Conditions studied include Arthritis, Rheumatoid, Lupus Erythematosus, Systemic and Rheumatic Diseases. GlaxoSmithKline sponsors the most, 3. Open Payments lists research payments to Dr. Antolini that name 3 trials.

CMS Open Payments shows 735 general payments to Dr. Antolini from 32 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 78% of the total. Amgen Inc. paid the most, $86,135. It also lists 15 research payments totaling $3,173 from 2018 to 2024, naming 3 clinical trials.

Dr. Antolini graduated from West Virginia University School of Medicine in 2002.